Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Korean Journal of Nuclear Medicine ; : 120-122, 2020.
Artigo em Inglês | WPRIM | ID: wpr-997469

RESUMO

The positron emission tomography (PET) flow tracer 82Rubidium is a known potassium analogue. During our studies oftumor blood flow in prostate cancer, we found that approximately 10% of the patients had high urinary 82Rubidiumactivity. In roughly half of these patients, the increased renal rubidium/potassium excretion was either causing hypokalemiaor explained by Thiazide treatment. In the other half, there was no obvious explanation or clinical consequence ofthe renal rubidium/potassium excretion. This is the first time enhanced renal potassium excretion is visualized on82Rubidium PET/CT.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA